anastrozole has been researched along with Adenocarcinoma in 13 studies
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The PCT responded partially to the cessation of oral contraceptives and to phlebotomy therapy to maintain low iron stores, but only remitted after she received anastrozole therapy for management of adenocarcinoma of the breast at age 59 years." | 8.84 | Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer. ( Barton, JC; Bertoli, LF, 2007) |
| " The PCT responded partially to the cessation of oral contraceptives and to phlebotomy therapy to maintain low iron stores, but only remitted after she received anastrozole therapy for management of adenocarcinoma of the breast at age 59 years." | 4.84 | Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer. ( Barton, JC; Bertoli, LF, 2007) |
| "Type I endometrial cancer is a common tumor of the female genital tract." | 2.53 | Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma. ( Babilonti, L; Bogliolo, S; Cassani, C; De Silvestri, A; Dominoni, M; Gaggero, CR; Gardella, B; Musacchi, V; Spinillo, A; Zanellini, F, 2016) |
| "Here we report a case of breast cancer that recurred after a 39-year latency period." | 2.50 | [A case of local recurrence developing thirty-nine years after mastectomy for breast cancer]. ( Kawano, K; Tashima, Y, 2014) |
| "We report a case of breast carcinoma metastatic to an epidural cervical meningioma, summarize the literature on metastases to central nervous system meningiomas, and suggest a possible mechanism." | 2.43 | Breast adenocarcinoma metastatic to epidural cervical spine meningioma: case report and review of the literature. ( Aghi, M; Brisman, JL; Kiehl, TR, 2005) |
| "The biology of metastatic breast cancer may demand palliation by oesophageal intubation or stenting combined with adjuvant chemo, radio or hormonal therapy in such instances." | 1.34 | [Solitary oesophageal metastasis of breast cancer after 17 years latency]. ( Kotsis, L; Kovács, O; Krasznai, G, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Ghadjar, P | 1 |
| Aebersold, DM | 1 |
| Albrecht, C | 1 |
| Böhmer, D | 1 |
| Flentje, M | 1 |
| Ganswindt, U | 1 |
| Höcht, S | 1 |
| Hölscher, T | 1 |
| Müller, AC | 1 |
| Niehoff, P | 1 |
| Pinkawa, M | 1 |
| Sedlmayer, F | 1 |
| Zips, D | 1 |
| Wiegel, T | 1 |
| Carpenter, NA | 1 |
| Crook, EK | 1 |
| Yanase, T | 1 |
| Kikuchi, A | 1 |
| Sasagawa, M | 1 |
| Honma, S | 1 |
| Tashima, Y | 1 |
| Kawano, K | 1 |
| Bogliolo, S | 1 |
| Gardella, B | 1 |
| Dominoni, M | 1 |
| Musacchi, V | 1 |
| Cassani, C | 1 |
| Zanellini, F | 1 |
| De Silvestri, A | 1 |
| Gaggero, CR | 1 |
| Babilonti, L | 1 |
| Spinillo, A | 1 |
| Bellone, S | 1 |
| Shah, HR | 1 |
| McKenney, JK | 1 |
| Stone, PJ | 1 |
| Santin, AD | 1 |
| Glück, S | 1 |
| Kaufman, B | 1 |
| Mackey, JR | 1 |
| Clemens, MR | 1 |
| Bapsy, PP | 1 |
| Vaid, A | 1 |
| Wardley, A | 1 |
| Tjulandin, S | 1 |
| Jahn, M | 1 |
| Lehle, M | 1 |
| Feyereislova, A | 1 |
| Révil, C | 1 |
| Jones, A | 1 |
| Bertolini, E | 1 |
| Letho-Gyselinck, H | 1 |
| Prati, C | 1 |
| Wendling, D | 1 |
| Aghi, M | 1 |
| Kiehl, TR | 1 |
| Brisman, JL | 1 |
| Margolis, R | 1 |
| Budd, GT | 1 |
| Singh, AD | 1 |
| Bertoli, LF | 1 |
| Barton, JC | 1 |
| Kovács, O | 1 |
| Kotsis, L | 1 |
| Krasznai, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Study of Pyrotinib in Combination With Fulvestrant in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive，Hormone Receptor（HR）-Positive Metastatic Breast Cancer[NCT04034589] | Phase 2 | 46 participants (Anticipated) | Interventional | 2019-07-17 | Recruiting | ||
| Phase II Open-label, Multicentre, Randomized Trial of Neoadjuvant Palbociclib in Combination With Hormonal Therapy and HER2 Blockade Versus Paclitaxel in Combination With HER2 Blockade for Postmenopausal Patients With Hormone Receptor Positive/HER2 Positi[NCT03644186] | Phase 2 | 144 participants (Actual) | Interventional | 2019-04-16 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for anastrozole and Adenocarcinoma
| Article | Year |
|---|---|
Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer.
Topics: Adenocarcinoma; Anastrozole; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormo | 2020 |
[A case of local recurrence developing thirty-nine years after mastectomy for breast cancer].
Topics: Adenocarcinoma; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Biopsy, Needle; Breast Neoplasms | 2014 |
Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma.
Topics: Adenocarcinoma; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Endometria | 2016 |
Exemestane as first-line therapy in postmenopausal women with recurrent or metastatic breast cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormona | 2010 |
Breast adenocarcinoma metastatic to epidural cervical spine meningioma: case report and review of the literature.
Topics: Adenocarcinoma; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carrier Proteins; Ce | 2005 |
Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer.
Topics: Adenocarcinoma; Adult; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraceptive | 2007 |
1 trial available for anastrozole and Adenocarcinoma
6 other studies available for anastrozole and Adenocarcinoma
| Article | Year |
|---|---|
MAMMARY GLAND ADENOCARCINOMA IN A MALE BORNEAN ORANGUTAN (PONGO PYGMAEUS).
Topics: Adenocarcinoma; Anastrozole; Animals; Antineoplastic Agents, Hormonal; Ape Diseases; Male; Mammary N | 2017 |
Two cases of endometrial cancer arising from adenomyosis during aromatase inhibitors therapy after mastectomy.
Topics: Adenocarcinoma; Adenomyosis; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Endometrial Neopla | 2017 |
Recurrent endometrial carcinoma regression with the use of the aromatase inhibitor anastrozole.
Topics: Adenocarcinoma; Anastrozole; Aromatase Inhibitors; Endometrial Neoplasms; Female; Humans; Immunohist | 2008 |
Rheumatoid arthritis and aromatase inhibitors.
Topics: Adenocarcinoma; Aged; Anastrozole; Androstadienes; Aromatase Inhibitors; Arthritis, Rheumatoid; Brea | 2011 |
Unusual macular degeneration following breast cancer.
Topics: Adenocarcinoma; Anastrozole; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms; Choroid Neoplas | 2007 |
[Solitary oesophageal metastasis of breast cancer after 17 years latency].
Topics: Adenocarcinoma; Anastrozole; Antineoplastic Agents, Hormonal; Biopsy; Breast Neoplasms; Chemotherapy | 2007 |